Boston Scientific to buy Symetis for $435 mln
Boston Scientific is buying Symetis for $435 million in cash. Symetris, of Ecublens, Switzerland, is a medical technology company that makes replacement heart valves.
30 March 2017•3 mins read
Boston Scientific is buying Symetis for $435 million in cash. Symetris, of Ecublens, Switzerland, is a medical technology company that makes replacement heart valves.
Walter Capital Partners takes significant stake in Quebec educational games maker Passe-Temps
15 hours ago · 1 min read
Truelink Capital’s GES buys CSG Creative from National Trade Productions
16 hours ago · 2 mins read
MPE Partners’ Intermatic adds outdoor lighting-control products maker Sun-Tech
16 hours ago · 2 mins read
Velocity Capital Management backs founder Griffin Haddrill with stake in LV8, Mirage
16 hours ago · 1 min read
Aterian’s Outlook Group completes acquisition of Graham-backed ABX’s Pewaukee packaging facility
16 hours ago · 1 min read
FPE Capital’s NoBlue2 adds PeopleWalking’s Spanish NetSuite business in Europe push
16 hours ago · 1 min read
PE targets identity security as AI transforms threats: 6 deals
18 hours ago · 3 mins read
